Internal Medicine, Nephrology · Rancho Mirage, CA
NPI
1417914193
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
71511 Highway 111, Suite H
Rancho Mirage, CA, 92270
Phone (760) 773-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$900K
14,445 services
Medicare patients, 2024
1,319
Average age 76
Drug cost, 2024
$1.5M
3,949 prescriptions
Company payments, 2025
$151K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rodolfo R Batarse was code 99457 (e&m - miscellaneous), 1,934 times for 216 patients. In total Rodolfo R Batarse billed 14,445 services in 33 codes, and Medicare paid $900K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 1,934 | 216 | $39.29 | $76K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,861 | 24 | $6.17 | $11K |
| 99454 E&M - Miscellaneous | Office | 1,811 | 207 | $39.12 | $71K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,756 | 826 | $12.76 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 1,299 | 296 | $61.46 | $80K |
| 99214 Office E&M - Established | Office | 1,217 | 705 | $93.56 | $114K |
| 99233 Hospital E&M - Subsequent | Facility | 776 | 257 | $92.00 | $71K |
| 99458 E&M - Miscellaneous | Office | 651 | 143 | $31.80 | $21K |
| 99211 Office E&M - Established | Office | 582 | 417 | $17.85 | $10K |
| 90960 ESRD Related Services (not dialysis) | Office | 539 | 133 | $279.70 | $151K |
| 90961 ESRD Related Services (not dialysis) | Office | 421 | 125 | $232.63 | $98K |
| 99223 Hospital E&M - Initial | Facility | 394 | 308 | $132.40 | $52K |
| 96372 Injection Administration | Office | 221 | 24 | $11.35 | $2,509 |
| 99205 Office E&M - New | Office | 189 | 189 | $161.03 | $30K |
| 90966 ESRD Related Services (not dialysis) | Office | 149 | 17 | $232.61 | $35K |
By year: 2022 $835K for 10,318 services; 2023 $811K for 10,071 services; 2024 $900K for 14,445 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rodolfo R Batarse prescribed most often to Medicare patients was Carvedilol, with 345 prescriptions and refills. In total Rodolfo R Batarse wrote 3,949 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 345 | 974 | 120 | $3,533 |
| Amlodipine Besylate Generic | 342 | 913 | 111 | $2,089 |
| Losartan Potassium Generic | 263 | 695 | 86 | $2,658 |
| Kerendia Finerenone | 262 | 388 | 44 | $245K |
| Farxiga Dapagliflozin Propanediol | 188 | 366 | 57 | $195K |
| Hydralazine Hcl Generic | 184 | 488 | 65 | $4,220 |
| Sevelamer Carbonate Generic | 147 | 274 | 43 | $25K |
| Veltassa Patiromer Calcium Sorbitex | 147 | 214 | 54 | $215K |
| Clonidine Hcl Generic | 138 | 355 | 45 | $2,340 |
| Lisinopril Generic | 123 | 367 | 44 | $891 |
| Bumetanide Generic | 120 | 299 | 47 | $5,220 |
| Furosemide Generic | 107 | 290 | 39 | $620 |
| Velphoro Sucroferric Oxyhydroxide | 103 | 154 | 31 | $249K |
| Metoprolol Succinate Generic | 93 | 268 | 31 | $2,447 |
| Minoxidil Generic | 91 | 213 | 29 | $2,875 |
Brand drugs: 1,146 claims; generic drugs: 2,803 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rodolfo R Batarse $151K ($151K in general payments such as food, travel and fees) from 20 companies. The largest payer was Ardelyx, Inc. with $58K.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 75 | $58K |
| Akebia Therapeutics Inc AKBA | 47 | $28K |
| Amgen Inc. AMGN | 23 | $24K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 20 | $17K |
| Calliditas Therapeutics US Inc. | 17 | $12K |
| Mallinckrodt Hospital Products Inc. | 15 | $6,545 |
| Fresenius USA Marketing, Inc. | 4 | $2,615 |
| Travere Therapeutics, Inc. TVTX | 9 | $223 |
| Vifor Pharma, Inc. | 11 | $206 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $195 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.